Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease
- 1 December 2015
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 63 (6) , 1405-1412
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Adipose tissue derived stromal stem cell therapy in murine ConA‐derived hepatitis is dependent on myeloid‐lineage and CD4+T‐cell suppressionEuropean Journal of Immunology, 2013
- Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusionFrontiers in Immunology, 2012
- Efficacy of adipose tissue‐derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin AJournal of Gastroenterology and Hepatology, 2011
- Immune-mediated liver injuryJournal of Hepatology, 2010
- Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6Cell Stem Cell, 2009
- Immunomodulatory properties of mesenchymal stromal cellsBlood, 2007
- Immunoregulatory function of mesenchymal stem cellsEuropean Journal of Immunology, 2006
- Immune modulation by mesenchymal stem cellsExperimental Cell Research, 2006
- Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cellsJournal of Clinical Investigation, 2002
- A T cell-dependent experimental liver injury in mice inducible by concanavalin A.Journal of Clinical Investigation, 1992